In 2018, the Ministry of Commerce recognized the “Guangdong Zhuhai National Foreign Trade Transformation and Upgrading Base (Biopharma) in Jinwan District,”. The biopharma Industrial is one of the six pillar industries in Zhuhai. It has developed into an area of 13 square kilometers, employs nearly 60,000 people, and gathers thousands of biopharmaceutical companies, making it a veritable " Drug Valley in South China ". After several years of cultivation, the base has gathered more than 120 well-known biopharmaceutical companies such as Livzon Pharmaceutical, Jianfan Bio, By-Health, Biolight, United Laboratories, Rundu Pharmaceuticals, Cardinal Medical, etc., forming biopharmaceuticals and chemical medicines. Medical equipment, health products, etc., a comprehensive and complete industrial chain. The products are exported to more than 130 countries and regions in Europe, the United States, South Asia, the Middle East, Africa, etc., occupying an important position in the global biomedical industry chain. With the acceleration of the high-quality development of the industry, a number of high-quality biomedical companies and a number of "fist products" have sprung up.
With the official approval of the national foreign trade transformation and upgrading base (Biopharma), it will help further promote the transformation and upgrading of Zhuhai’s foreign trade, enhance international competitiveness, and play a positive role in the construction of a higher level of open economy in Zhuhai and the realization of high-quality development. Promote the role. The Jinwan Biopharma Base built by Zhuhai City is not only one of the three major biomedical industry clusters in Guangdong, but also the only "national foreign trade transformation and upgrading base" in the Mainland that can connect Hong Kong and Macao by land bridge.
